Location History:
- Salt Lake City, UT (US) (2002 - 2004)
- Satl Lake City, UT (US) (2004)
Company Filing History:
2 out of 10 
1 out of 1,645 
2 out of 832,843 Years Active: 2002-2004
Title: John D Wagstaff: Innovator in Neuromuscular and Neuroprotective Therapies
Introduction
John D Wagstaff is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmacology, particularly in the development of neuromuscular blocking agents and neuroprotective therapies. With a total of 5 patents to his name, Wagstaff's work has the potential to impact various medical treatments.
Latest Patents
Wagstaff's latest patents include groundbreaking inventions such as mu-conopeptides. This invention focuses on the use of μ-conopeptides, their derivatives, and pharmaceutically acceptable salts for treating disorders associated with voltage-gated sodium channels. These peptides are particularly useful as neuromuscular blocking agents, local anesthetics, analgesics, and neuroprotective agents. Additionally, he has developed nucleic acid sequences encoding these peptides, which further enhances their therapeutic applications.
Another significant patent is related to Contulakin-G and its analogs. This invention encompasses the native glycosylated peptide, des-glycosylated variants, and their derivatives. The therapeutic applications of this peptide are extensive, targeting conditions such as seizures, inflammation, and various neurological disorders. The versatility of these inventions highlights Wagstaff's innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Wagstaff has worked with various companies, including Cognetix, Inc. His experience in these organizations has allowed him to refine his research and contribute to the advancement of medical science. His work has not only led to patents but has also paved the way for new therapeutic options in the medical field.
Collaborations
Wagstaff has collaborated with notable individuals in his field, including Baldomero M Olivera and Lourdes J Cruz. These partnerships have likely enriched his research and contributed to the success of his inventions.
Conclusion
John D Wagstaff is a prominent inventor whose work in neuromuscular and neuroprotective therapies has the potential to transform medical treatments. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.